Table 1.
Baseline characteristics of patients, presence of comorbidities and progression of disease and medications.
| Total no. of patients | 220 |
|---|---|
| Sex | |
| Female | 132 |
| Male | 88 |
| Average Age | 48 |
| A Category | 66 |
| B Category | 154 |
| C Category | 0 |
| No. of patients hospitalized after enrolled in VCIP | 2 |
| Presence of Comorbidities | 154 |
| Diabetes | 107 |
| Prediabetes | 15 |
| HTN | 30 |
| Dyslipidemia | 109 |
| Asthma | 2 |
| Chronic Liver Disease | 1 |
| Progression of disease and medications | |
| Patients progressed from A to B | 0 |
| Patients progressed from B to C | 1 |
| No. of patients on steroids in Category A (4 mg OD 7 days) | 1 |
| No. of patients on LMWH in Category A (0.4 ml OD Sc 7 days) | 9 |
| No. of patients on steroids in Category B (4 mg BD for 7 days) | 6 |
| No. of patients on steroids in Category B (4 mg BD for 7 days) | 57 |
| No. of patients on LMWH in Category B (0.4 ml OD for 7 days) | 92 |